In a BCR/ABL1+ B-ALL patient, the “Stem/B” cells selectively persisted at remission, whereas no BCR/ABL1+ lymphoid cells could be observed in the other B-cell populations. Here, ABL1 is linked to acute lymphoblastic leukemia.